$5.3B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | RVMD Revolution Medicines Inc | 6.4M | −4.4% | $1.2B | 22.3% |
| 2 | NUVALENT INC Nuvalent Inc | 5.9M | +11.3% | $732M | 13.7% |
| 3 | EWTX Edgewise Therapeutics Inc | 10.2M | +38.7% | $415M | 7.8% |
| 4 | GMAB Genmab A/S | 13.1M | +64.8% | $361M | 6.8% |
| 5 | SYRE Spyre Therapeutics Inc | 3.8M | +96.2% | $341M | 6.4% |
| 6 | APOGEE THERAPEUTICS INC Apogee Therapeutics Inc | 1.6M | +16.9% | $209M | 3.9% |
| 7 | ORKA Oruka Therapeutics Inc | 2.1M | −7.6% | $204M | 3.8% |
| 8 | TNGX Tango Therapeutics Inc | 6.4M | +58.6% | $199M | 3.7% |
| 9 | BLTE Belite Bio Inc | 1.2M | +10.6% | $190M | 3.6% |
| 10 | ERAS Erasca Inc | 9.6M | −8.1% | $175M | 3.3% |
| 11 | TARS Tarsus Pharmaceuticals Inc | 2.8M | +8.3% | $175M | 3.3% |
| 12 | ALNY Alnylam Pharmaceuticals Inc | 480,000 | — | $144M | 2.7% |
| 13 | INSM Insmed Inc | 1.3M | +5.7% | $141M | 2.6% |
| 14 | MBX Mbx Biosciences Inc | 2.5M | — | $138M | 2.6% |
| 15 | PCVX Vaxcyte Inc | 2.1M | −55.6% | $124M | 2.3% |
| 16 | VRDN Viridian Therapeutics Inc | 6.7M | +113.5% | $124M | 2.3% |
| 17 | OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc | 8.7M | +8.1% | $108M | 2.0% |
| 18 | JBIO Jade Biosciences Inc | 2.9M | — | $63M | 1.2% |
| 19 | TYRA Tyra Biosciences Inc | 1.8M | −11.0% | $58M | 1.1% |
| 20 | ASMB Assembly Biosciences Inc | 1.6M | +133.6% | $43M | 0.8% |
| 21 | EYPT Eyepoint Inc | 2.9M | −8.0% | $41M | 0.8% |
| 22 | QUIT Achieve Life Science Inc | 5.0M | — | $32M | 0.6% |
| 23 | VOR Vor Biopharma Inc | 1.8M | +0.0% | $32M | 0.6% |
| 24 | MPLT Maplight Therapeutics Inc | 685,852 | — | $25M | 0.5% |
| 25 | KARD Kardigan Inc | 900,000 | — | $21M | 0.4% |
| 26 | LXEO Lexeo Therapeutics Inc | 4.2M | −32.5% | $19M | 0.4% |
| 27 | EDIT Editas Medicine Inc | 5.6M | — | $18M | 0.3% |
| 28 | IVA Inventiva Sa | 4.0M | +0.0% | $15M | 0.3% |